In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing.

Experts on call Ulrich Neumann, Sr. Director, US Access ulrich.neumann@certara.com

Additional notes: - We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449. DOI: 10.1257/jel.20161327

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Certara Evidence & Access. Innehållet i podden är skapat av Certara Evidence & Access och inte av, eller tillsammans med, Poddtoppen.